Background: The Industrial Internet of Things (IIoT) connects devices, sensors, and advanced analytics systems within industrial settings to optimize operations, enhance data visibility, and support real-time decision-making. In the pharmaceutical industry, IIoT is becoming a tra...
Open access
Research Article10.9734/ajrimps/2025/v14i3313
Background: Human papillomavirus (HPV) is a sexually transmitted infection that affects approximately 70% of individuals during their lifetime, with approximately 47 million women aged 15 years and older at risk of developing the disease in Nigeria. Studies have revealed that HPV...
Open access
Research Article10.9734/ijpr/2025/v14i2356
Background: Doxorubicin (DOX) is a potent chemotherapeutic agent with a broad spectrum of anticancer activity. However, its clinical utility is limited by its propensity to induce cardiotoxicity, characterized by oxidative stress and myocardial degeneration. Objective: This study...
Open access
Research Article10.9734/ajrcd/2025/v7i1122
Background: The increasing complexity of modern healthcare has driven interest in artificial intelligence (AI) systems capable of supporting decision-making, optimizing workflows, and enhancing patient outcomes. Among the most advanced technologies are multi-agent AI systems netw...
Open access
Research Article10.9734/ajmpcp/2025/v8i1288
Background and Objectives: Poliovirus, a highly infectious viral disease, has been a major public health concern in Nigeria. Despite the country’s successful eradication of wild poliovirus in 2020, outbreaks of circulating vaccine-derived poliovirus type 2 continue to pose signif...
Open access
Research Article10.9734/ijpr/2025/v14i3360
Background and Objectives: Sickle cell disease is one of the most prevalent genetic disorders in Nigeria, contributing significantly to infant and under-five mortality. Despite advances in early detection through newborn screening, uptake in Nigeria remains limited, particularly...
Open access
Research Article10.9734/ajmpcp/2025/v8i1287